Provivi Inc.

SANTA MONICA, CA · Founded 2012 · CIK 0001634122 · Biotech · Private

Biochemical crop protection agents produced through fermentation and synthetic biology

provivi.com →
Grants
$1.5M
3 awards
Sector median: 1
Raised
$77M
7 Form D · Sep 2026
0 months since last filing
Contracts
—
No federal contracts on record
Patents
40
22 granted · 18 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: Enzymatic Synthesis of Chiral Cyclopropanes for Pharmaceutical Drug Synthesis and Agricultural Crop Protection Applications$225,000
Private capital raised· 1 of 2 same dayForm D · SEC$1,000,000
Private capital raised· 2 of 2 same dayForm D · SEC$1,000,000
Private capital raisedForm D · SEC$6,686,106
Federal grantNational Science Foundation · Phase II · SBIR Phase II: Enzymatic Synthesis of Insect Pheromones$737,990
Federal grantNational Science Foundation · Phase II · STTR Phase II: Enzymatic Synthesis of Chiral Cyclopropanes for Pharmaceutical Drug Synthesis and Agricultural Crop Protection Applications$568,086
Private capital raisedForm D · SEC$8,967,931
Private capital raisedForm D · SEC$34,181,624
Private capital raisedForm D · SEC$25,499,320
Private capital raisedForm D · SEC$2,500,000
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3002Riboscience LLC——
3003AAIIT LLC——
3004Structure Therapeutics——
3005Provivi Inc.—$77M
3006REVERSAL THERAPEUTICS INC——
3007EARNANO, LLC——
3008SPEKCITON BIOSCIENCES LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 11 related persons
  • Frances ArnoldDirector
  • ALAN BOYCEDirector
  • Pedro CoelhoDirector · Executive Officer
  • James DemetriadesDirector
  • Corey HuckDirector · Executive Officer
  • Ganesh KishoreDirector
  • GANESH KISHOREDirector
  • Paul KucExecutive Officer
  • Peter MeinholdExecutive Officer
  • Ronald OlsonDirector
  • TULIO RIBEIRODirector

Patents

USPTO · 22 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.